Results 31 to 40 of about 233,958 (293)

Angiogenic potential of endothelial progenitor cells and embryonic stem cells [PDF]

open access: yes, 2011
Background: Endothelial progenitor cells (EPCs) are implicated in a range of pathological conditions, suggesting a natural therapeutic role for EPCs in angiogenesis.
St John, Justin   +15 more
core   +1 more source

CD144, CD146 and VEGFR-2 properly identify circulating endothelial cell

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2015
Studies evaluating circulating endothelial cells by flow cytometry are faced by a lack of con- sensus about the best combination of monoclonal antibodies to be used. The rarity of these cells in peripheral blood, which represent 0.01% of mononuclear cells,
Mariane Cristina Flores-Nascimento   +3 more
doaj   +1 more source

Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease. [PDF]

open access: yesPLoS ONE, 2014
In chronic obstructive pulmonary disease (COPD), decreased progenitor cells and impairment of systemic vascular function have been suggested to confer higher cardiovascular risk.
Sandra Pizarro   +11 more
doaj   +1 more source

Circulating Endothelial Cells and Vasculitis

open access: yesInternal Medicine, 2004
Systemic vasculitides are a heterogeneous group of disorders with inflammation of blood vessels as their common pathogenetic hallmark. They often pose difficulties with regard to diagnosis and monitoring of disease activity, both at the initial presentation and during follow-up.
HAUBITZ, Marion, WOYWODT, Alexander
openaire   +3 more sources

Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells [PDF]

open access: yes, 2009
Background Transplantation of vasculogenic progenitor cells (VPC) improves neovascularization after ischemia. However, patients with type 2 diabetes mellitus show a reduced VPC number and impaired functional activity. Previously, we demonstrated that p38
Aicher Alexandra   +17 more
core   +1 more source

Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes [PDF]

open access: yes, 2003
Background - Further to promoting angiogenesis, cell therapy may be an approach for cardiac regeneration. Recent studies suggest that progenitor cells can transdifferentiate into other lineages. However, the transdifferentiation potential of endothelial
Dimmeler, S   +9 more
core   +1 more source

Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema.

open access: yesPLoS ONE, 2017
Endothelial injury is implicated in the pathogenesis of COPD and emphysema; however the role of endothelial progenitor cells (EPCs), a marker of endothelial cell repair, and circulating endothelial cells (CECs), a marker of endothelial cell injury, in ...
Margaret F Doyle   +13 more
doaj   +1 more source

Decreased numbers of circulating endothelial progenitor cells are associated with hyperglycemia in patients with traumatic brain injury

open access: yesNeural Regeneration Research, 2019
Hyperglycemia reduces the number of circulating endothelial progenitor cells, accelerates their senescence and impairs their function. However, the relationship between blood glucose levels and endothelial progenitor cells in peripheral blood of patients
Hui-Jie Wei   +9 more
doaj   +1 more source

The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study [PDF]

open access: yes, 2015
Background: Type 1 diabetes is associated with raised inflammation, impaired endothelial progenitor cell mobilisation and increased markers of vascular injury. Both acute and chronic exercise is known to influence these markers in non diabetic controls,
Wijaya, Stephanie   +39 more
core   +1 more source

Circulating Microparticles Are Elevated in Treated HIV‐1 Infection and Are Deleterious to Endothelial Cell Function

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Circulating microparticles have emerged as biomarkers and effectors of vascular disease. Elevated rates of cardiovascular disease are seen in HIV‐1–seropositive individuals.
Jamie G. Hijmans   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy